Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W N Keith

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Methods in Molecular Medicine|March 5, 2011
Genetic analysis of drug resistance by reverse in situ hybridizationW N Keith
Methods in Molecular Medicine|March 5, 2011
Genetic analysis of drug resistance by fluorescence in situ hybridizationW N Keith
Anticancer Research|September 1, 1991
Carcinogenesis and the response of tumours to anticancer drugsW N Keith, R Brown
British Journal of Cancer|August 1, 1996
Variation in topoisomerase I gene copy number as a mechanism for intrinsic drug sensitivityH L McLeod, W N Keith
Biochimie|September 15, 2007
Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activityC J Cairney, W N Keith
British Journal of Cancer|January 31, 2008
Targeting telomerase for cancer therapeuticsJ W Shay, W N Keith
British Journal of Cancer|May 1, 1990
Expression of mdr1 and gst-pi in human breast tumours: comparison to in vitro chemosensitivityW N Keith, S Stallard, R Brown
Minerva Ginecologica|February 25, 2005
Intra-peritoneal administration of genetic therapies: promises and pitfallsT R J Evans, W N Keith
Biogerontology|July 9, 2011
Progeroid syndromes: models for stem cell aging?I Bellantuono, G Sanguinetti, W N Keith
Cancer Research|November 1, 1990
Response of mouse skin tumors to doxorubicin is dependent on carcinogen exposureW N Keith, P J Mee, R Brown
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Methods in Molecular Medicine|March 5, 2011
Genetic analysis of drug resistance by reverse in situ hybridizationW N Keith
Methods in Molecular Medicine|March 5, 2011
Genetic analysis of drug resistance by fluorescence in situ hybridizationW N Keith
Anticancer Research|September 1, 1991
Carcinogenesis and the response of tumours to anticancer drugsW N Keith, R Brown
British Journal of Cancer|August 1, 1996
Variation in topoisomerase I gene copy number as a mechanism for intrinsic drug sensitivityH L McLeod, W N Keith
Biochimie|September 15, 2007
Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activityC J Cairney, W N Keith
British Journal of Cancer|January 31, 2008
Targeting telomerase for cancer therapeuticsJ W Shay, W N Keith
British Journal of Cancer|May 1, 1990
Expression of mdr1 and gst-pi in human breast tumours: comparison to in vitro chemosensitivityW N Keith, S Stallard, R Brown
Minerva Ginecologica|February 25, 2005
Intra-peritoneal administration of genetic therapies: promises and pitfallsT R J Evans, W N Keith
Biogerontology|July 9, 2011
Progeroid syndromes: models for stem cell aging?I Bellantuono, G Sanguinetti, W N Keith
Cancer Research|November 1, 1990
Response of mouse skin tumors to doxorubicin is dependent on carcinogen exposureW N Keith, P J Mee, R Brown
Pageof 5